Vol 15, No 3 (June 30, 2024): Journal of Gastrointestinal Oncology

Original Article

Prognosis for local radical treatment in patients with esophageal squamous cell carcinoma with low-risk oligometastatic recurrence after curative resection: a retrospective cohort study
Tingting Li, Dongmei Ke, Xiaobin Fu, Yaqing Dai, Jules Lin, Christopher J. Anker, Zhigang Bai, Jiancheng Li
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:807-817
.
SPP1 promotes tumor progression in esophageal carcinoma by activating focal adhesion pathway
Jianjun Sun, Mingming Tang, Zhigang Cai
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:818-828
.
Identification of a prognostic DNA repair gene signature in esophageal cancer
Hailei Du, Xinyi Wang, Shanshan Xie, Alfredo Tartarone, Emmanuel Gabriel, Jeffrey B. Velotta, Pierlorenzo Pallante, Lianggang Zhu, Junbiao Hang, Ling Chen
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:829-840
.
Safety and short-term outcomes of esophagectomy after neoadjuvant immunotherapy combined with chemotherapy or chemoradiotherapy for locally advanced esophageal squamous cell cancer: analysis of two phase-II clinical trials
Dijian Shen, Runzhe Chen, Qing Wu, Yongling Ji, Berend J. van der Wilk, Emerson Y. Chen, Qixun Chen, Ming Chen
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:841-850
.
Risk of de novo esophageal cancer in liver transplant recipients: systematic review and meta-analysis
Shaoya Li, Shutian Zhang, Xiujing Sun
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:851-861
.
ARID1A is involved in DNA double-strand break repair in gastric cancer
Ying Zhang, He-Sheng Qian, Gengwei Hu, Lu Wang, Yiping Zhu
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:862-872
.
Identification and validation of Cystatin A as a novel promising therapeutic target for gastric cancer
Qingyu Xu, Shuai Xue, Yaqiong Zhang, Jian Li, Peiyu Qian, Yanyan Zhang, Li Feng
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:873-889
.
Role of TAP1 in the identification of immune-hot tumor microenvironment and its prognostic significance for immunotherapeutic efficacy in gastric carcinoma
Zehua He, Hong Yang, Qingfeng Chen, Yi-Ping Phoebe Chen, Huabo Qin, Wanrong He, Zhihui Chen
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:890-907
.
Survival outcome and prognostic factors of remnant gastric cancer: a propensity score-matched analysis
Shangcheng Yan, Qiankun Shao, Wei Peng, Ming Cheng, Tianhua Liu, Mengchao Sheng, Rui Ren, Qiang Chen, Wei Gong, Yongyou Wu
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:908-920
.
Efficacy of first-line chemotherapy based on primary site of tumor versus etoposide-platinum in advanced gastroenteropancreatic neuroendocrine carcinoma
Haoyang Shen, Yunru Gu, Yuan Fang, Tingting Xu, Yangyue Xu, Xi Wu, Yongqian Shu, Pei Ma
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:921-930
.
Survival outcomes and prognostic factors of advanced gastrointestinal stromal tumors: in the era of multiple tyrosine kinase inhibitors
Jinjin Li, Zhen Huang, Hui Zhou, Haitao Li, Jun Zhang
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:931-945
.
Multi-omics analysis of the prognostic and biological role of cuproptosis-related gene in gastric cancer
Ruopeng Zhang, Feiyang Zhang, Zekun Liu, Yuqian Huang, Yinghe Li, Baiwei Zhao, Wanqi Chen
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:946-962
.
Gastric and colorectal cancer incidence attributable to dietary factors in Korea
Hyun Jeong Cho, Hae Dong Woo, Sohee Park, Wook Jin Choi, Ji Hyun Kim, Sun-Seog Kweon, Jeongseon Kim, Jung Eun Lee, Sue K. Park
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:963-973
.
The roles and mechanisms of APOL1 in the development of colorectal cancer
Feipeng Xu, Weiwei Wang, Qidong Li, Lirui Zou, Huilai Miao
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:974-986
.
Efficacy and safety of regorafenib in the treatment of metastatic colorectal cancer: a retrospective cohort study
Hao Yan, Jindong Liu, Yifan Zhang, Shuo Chen, Jing Xu, Dandan Gao, Haipeng Li, Xinyue Fang, Yu Wang, Huaqing Wang, Hui Wang
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:987-1001
.
Unveiling the impact of glutathione (GSH) and p53 gene deletion on tumor cell metabolism by amino acid and proteomics analysis
Hui Zhang, Jing Zhou, Lei Dong, Liyu Zhu, Yingjiang Ye
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:1002-1019
.
Senescence-related signatures predict prognosis and response to immunotherapy in colon cancer
Xiaoshan Hu, Xiongjie Zhu, Yifan Chen, Wenkai Zhang, Laiqing Li, Huankun Liang, Bekzod B. Usmanov, Matteo Donadon, Abrorjon A. Yusupbekov, Yanfang Zheng
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:1020-1034
.
B7-H3 enhances colorectal cancer progression by regulating HB-EGF via HIF-1α
Chenrui Hu, Shengjia Wang, Jin Wang, Xiaokang Ruan, Linwei Wu, Zhe Zhang, Xuefeng Wang, Jianglei Zhang, Yonghao Liu, Yao Li, Xin Zhao
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:1035-1049
.
A single arm phase 2 clinical trial of YIV-906 with neoadjuvant concurrent chemo-radiation therapy in patients with locally advanced rectal cancer
Nipun Verma, Kimberly L. Johung, Jeremy Kortmansky, Wajih Zaheer, Jill Lacy, Michael Cecchini, Stacey Stein, Yung-Chi Cheng, Wing Lam, Shwu-Huey Liu, Vikram Reddy, Howard Hochster, Susan A. Higgins
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:1050-1059
.
Predicting bowel function after diverting stoma closure in patients with rectal cancer
Zhang Wang, Shengli Shao, Lu Liu, Qiyi Lu, Lei Mu, Jichao Qin
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:1060-1071
.
Efficacy and safety of regorafenib as a first-line agent alone or in combination with an immune checkpoint inhibitor for advanced hepatocellular carcinoma: a retrospective cohort study
Jianfa Yu, Yi Bai, Zilin Cui, Chuanliang Cheng, Morten Ladekarl, Kai-Chi Cheng, Kai Siang Chan, Hooman Yarmohammadi, José L. Mauriz, Yamin Zhang
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:1072-1081
.
A machine learning clinic scoring system for hepatocellular carcinoma based on the Surveillance, Epidemiology, and End Results database
Yueqing Wu, Chenyi Zhuo, Yuan Lu, Zongjiang Luo, Libai Lu, Jianchu Wang, Qianli Tang, Meaghan M. Phipps, William J. Nahm, Antonio Facciorusso, Bin Ge
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:1082-1100
.
Transarterial chemoembolization using drug-eluting beads versus lipiodol in the treatment of unresectable hepatocellular carcinoma: propensity score matching
Gengfei Cao, Junpeng Gu, Haixiao Zhang, Weizheng Ji, Diwen Zhu, Yingjun Bao, Haer Asi, Weixin Ren
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:1101-1111
.
Prognosis comparison between hepatocellular carcinoma patients with microvascular invasion who received hepatectomy alone and those who underwent early PA-TACE: a retrospective cohort study
Zhiping Ma, Wei Zhou, Heqing Huang, Yunhai Yao
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:1112-1121
.
Clinical features and prognostic factors of patients with inoperable hepatocellular carcinoma treated with chemotherapy: a population-based study
Yang Gao, Yihang Xu, Yong Wang, Jian Lu, Jin-He Guo
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:1122-1140
.
Clinical impact and potential utility of non-enhanced computed tomography performed immediately after transarterial chemoembolization for hepatocellular carcinoma
Mi Young Kim, Subin Heo, Sejin Choi, Chong Hyun Suh, Eun Seoung Lee, Hyo Jung Park, Kyung Won Kim
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:1141-1152
.
Comparing laparoscopic and open resection in elderly hepatocellular carcinoma: a systematic review and meta-analysis
Jeong-Ju Yoo, Dong Ah Park, Seungeun Ryoo, Jungeun Park, Gi Hong Choi
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:1153-1164
.
The EFNA4 gene is a potential prognostic biomarker in pancreatic cancer: a bioinformatics analysis
Qiuwen Ye, Dong Chen, Xin Liu, Burong Yang, Gang Li, Jun Ma, Liang Ai, Zhilin Li, Huaiyong Yang, Tingdong Yu, Jing Tan
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:1165-1178
.
Identification of pancreatic adenocarcinoma immune subtype associated with tumor neoantigen from aberrant alternative splicing
Qiong Du, Zhan Yu, Zifeng Zhang, Jianhui Yang, Nicolas Jonckheere, Si Shi, Wei Wang, Jin Xu, Jiyong Liu, Xianjun Yu
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:1179-1197
.
Promotion of perineural invasion of cholangiocarcinoma by Schwann cells via nerve growth factor
Xingwang Qian, Enchi Liu, Chong Zhang, Ruo Feng, Nguyen Tran, Wenlong Zhai, Fazhan Wang, Zhihai Qin
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:1198-1213
.
Association between type 2 diabetes, alcohol intake frequency, age at menarche, and gallbladder cancer: a two-sample Mendelian randomization study
Minling Cheng, Xueyin Zhou, Yaoting Xue, Enjie Zhou, Jiahao Hu, Jingkai Xu, Bin Zhang, Jiliang Shen, Jinming Zhang, Zhehan Chen, Bowen Wu, Shuyou Peng, Tuck-Whye Wong, Jiasheng Cao, Mingyu Chen
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:1214-1223
.
MMP11 as a prognostic biomarker correlated with immune infiltrates in pancreatic adenocarcinoma
Zhengxuying Fang, Xiaoyu Xu, Linglong Tao, Leonardo S. Lino-Silva, Yi Lu
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:1224-1244
.
Reappraisal of the current resectability criteria and optimal treatment strategies for pancreatic cancer
Suguru Yamada, Kenji Oshima, Kosuke Nomoto, Yuki Sunagawa, Yukiko Oshima, Akimasa Nakao
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:1245-1254
.
Treatment outcomes of endoscopic resection for nonampullary duodenal neuroendocrine tumors
Wenyu Li, Yong Liu, Lizhou Dou, Shun He, Yueming Zhang, Yan Ke, Xudong Liu, Guiqi Wang
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:1255-1264
.
Identifying drug candidates for pancreatic ductal adenocarcinoma based on integrative multiomics analysis
Penglei Ge, Zhengfeng Wang, Weiwei Wang, Zhiqiang Gao, Dingyang Li, Huahu Guo, Shishi Qiao, Xiaowei Dang, Huayu Yang, Yang Wu
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:1265-1281
.

Review Article

Lactic acid: a narrative review of a promoter of the liver cancer microenvironment
Junhe Chen, Guifang He, Duo Cai, Elisa Giovannetti, Kentaro Inamura, Shihai Liu, Wenzhe Ma
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:1282-1296
.
The application of graphene oxide and ferroptosis in the diagnosis and treatment of colorectal cancer: a narrative review
Xiecheng Zhou, Qixing Zhang, Haoran Zhu, Jiaying Zhao, Yuankun Cai
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:1297-1308
.

Case Report

An unusual presentation of solitary ovarian metastasis from colorectal cancer in an elderly woman: a case report
Fei Tang, Limei Ji, Kaiqiang Hu, Liujuan Shao, Min Hu
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:1309-1314
.
Transcatheter arterial chemoembolization with tyrosine kinase inhibitor in the 12-year treatment of hepatic metastases from gastrointestinal stromal tumor: a case report
Binggen Yu, Jianjun Luo, Jiping Wu, Lisong Gu, Yunyun Zhang
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:1315-1323
.
Severe febrile neutropenia and pancytopenia in a patient with advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab: a case report
Shadi Chamseddine, Michael LaPelusa, Kristen Carter, Van Nguyen, Yehia I. Mohamed, Yara Sakr, Cristhiam M. Rojas-Hernandez, Rikita I. Hatia, Manal Hassan, John A. Goss, Khaled M. Elsayes, Asif Rashid, Ryan Sun, Hop Sanderson Tran Cao, Hesham M. Amin, Ahmed O. Kaseb
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:1324-1330
.
Intrathecal topotecan with systemic checkpoint inhibitor therapy for gastroesophageal cancer with leptomeningeal involvement: two case reports and review of the literature
Cindy M. Pabon, Debra N. Yeboa, Barbara J. O’Brien, Nazanin K. Majd, Chenyang Wang, Mariela A. Blum Murphy
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:1331-1340
.
Minimal residual disease monitoring via ctDNA: a case report of Lynch syndrome with synchronous colorectal cancer and review of literature
Cody Eslinger, Christina Wu, Daniel H. Ahn
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:1341-1347
.

Study Protocol

Hepatic artery infusion pump (HAIP) therapy in combination with targeted delivery of IL-12 for patients with metastatic colorectal cancer or intrahepatic cholangiocarcinoma: a phase II trial protocol
Jack H. Victory, Emily C. Smith, Carrie E. Ryan, Jacob Lambdin, Amber Leila Sarvestani, Lindsay R. Friedman, Alyssa V. Eade, Carolina Larrain, Tracey Pu, Kenneth Luberice, Bhavishya Ramamoorthy, Ashley J. Rainey, Cathleen E. Hannah, Kathleen M. Smith, Donna Mabry, Changqing Xie, Jeremy L. Davis, Andrew M. Blakely, James L. Gulley, Jeffrey Schlom, Cecilia Monge, Tim F. Greten, Jonathan M. Hernandez
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:1348-1354
.

Editorial

Recognizing and navigating barriers to hope in gastrointestinal cancer patients
Deepak Venkataraman, Devika Rao
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:1355-1357
.
Emerging role of circulating tumor DNA for early detection of recurrence in biliary tract cancers
Matthew D. Bloom, Babar Bashir
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:1358-1362
.

Letter to the Editor

Assessment of preoperative short-term parenteral nutrition in gastric cancer surgery
Yunlong Dai, Qingbo Feng
Journal of Gastrointestinal Oncology  
2024;
15
(3)
:1363-1364
.